MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03175cam a22003618i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
17544795 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
EG-NcFUE |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20230824160759.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
121128s2013 stk b 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780702042904 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780702042911 (International) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(DNLM)101596715 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DNLM/DLC |
| Transcribing agency |
DLC |
| Description conventions |
rda |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.19 |
| Edition number |
23 |
| Item number |
A. |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Aulton's pharmaceutics : |
| Remainder of title |
the design and manufacture of medicines / |
| Statement of responsibility, etc |
edited by Michael E. Aulton and Kevin M.G. Taylor. |
| 246 1# - VARYING FORM OF TITLE |
|---|
| Title proper/short title |
Pharmaceutics |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
4th edtion |
| 264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Edinburgh : |
| Name of publisher, distributor, etc |
Churchill Livingstone/Elsevier, |
| Date of publication, distribution, etc |
2013 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xiii, 894 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
25 cm |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Source |
rdacarrier |
| 500 ## - GENERAL NOTE |
|---|
| General note |
pharmacy bookfair2015 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
1. Design of dosage forms. PART 1: Scientific principles of dosage form design. 2. Dissolution and solubility. 3. Properties of solutions. 4. Surfaces and interfaces. 5. Disperse systems. 6. Rheology. 7. Kinetics. PART 2: Particle science and powder technology. 8. Solid-state properties. 9. Particle size analysis. 10. Particle size reduction and size separation. 11. Mixing. 12. Powder flow. PART 3: Pharmaceutical microbiology and sterilization. 13. Fundamentals of microbiology. 14. Pharmaceutical applications of microbiological techniques. 15. Action of physical and chemical agents on microorganisms. 16. Principles of sterilization. 17. Sterilization in practice. PART 4: Biopharmaceutical principles of drug delivery. 18. Introduction to biopharmaceutics. 19. Gastrointestinal tract - physiology and drug absorption. 20. Bioavailability - physicochemical and dosage form factors. 21. Assessment of biopharmaceutical properties. 22. Dosage regimens. PART 5: Dosage form design and manufacture. 23. Pharmaceutical preformulation. 24. Solutions. 25. Clarification. 26. Suspensions . 27. Emulsions and Creams. 28. Powders, granules and granulation. 29. Drying. 30. Tablets and compaction. 31. Modified-release oral drug delivery. 32. Coating of tablets and multiparticulates. 33. Hard capsules. 34. Soft capsules. 35 Dissolution testing of solid dosage forms. 36 Parenteral drug delivery. 37. Pulmonary drug delivery. 38. Nasal drug delivery. 39. Topical and transdermal drug delivery. 40. Wound dressings. 41. Ocular drug delivery. 42. Rectal and vaginal drug delivery. 43. Design and administration of medicines for children and the elderly. 44. The formulation and manufacture of plant medicines. 45. Pharmaceutical nanotechnology and nanomedicines. 46. Delivery of biopharmaceuticals. Part 6: PACKAGING AND STABILITY OF PHARMACEUTICAL PRODUCTS. 47. Packaging. 48. Chemical stability in dosage forms. 49. Product stability and stability testing. 50. Microbial contamination, spoilage and preservation of medicines. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Dosage Forms. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Biopharmaceutics |
| General subdivision |
methods. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug Compounding |
| General subdivision |
methods. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug Design. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Aulton, Michael E. |
| Relator term |
editor |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Taylor, Kevin, |
| Dates associated with a name |
1961-, |
| Relator term |
editor |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Books |